Management Practice for Hordeolum and Chalazion: A Survey of the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS) Members |
Hyun Jin Shin1,2,3, Jin Sook Yoon4, Hokyung Choung5, Helen Lew6 |
1Department of Ophthalmology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea 2Research Institute of Medical Science, Konkuk University, Seoul, Korea 3Institute of Biomedical Science and Technology, Konkuk University, Seoul, Korea 4Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 5Department of Ophthalmology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea 6Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam, Korea |
Correspondence:
Helen Lew, Tel: 82-31-780-5330, Fax: 82-31-780-5333, Email: eye@cha.ac.kr |
Received: 26 February 2025 • Revised: 13 April 2025 • Accepted: 22 April 2025 |
Abstract |
Purpose To determine the current management pattern for hordeolum and chalazion among members of the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS).
Methods An anonymous web-based survey was emailed to 260 current members of the KSOPRS. The survey comprised five sections: differential diagnosis, treatment strategies for hordeolum, treatment strategies for chalazion, postsurgical care, and pediatric-specific approaches.
Results Eighty KSOPRS members participated in this study (response rate, 30.8%). Redness, swelling, and pain were the most important factors for differentiating hordeolum from chalazion. For hordeolum, topical antibiotics are preferred by 59 respondents (73.8%), with 49 (83.7%) considering them effective. Most (62 respondents, 77.6%) pursue nonsurgical treatment for 5 to 14 days before considering incision and curettage. For chalazion, treatment practices are split between conservative management and invasive methods. Intralesional steroid injections are recommended by 55 respondents (68.8%), with a preference for diluted triamcinolone acetonide. Relative to hordeolum, chalazion treatment involves less frequent antibiotic use, with only 21 respondents (26.3%) always recommending antibiotic ointments. Tissue biopsy is considered for abnormal changes in the surrounding tissues (72 respondents, 90.0%) and frequent recurrence (46 respondents, 57.5%). The practices differ between pediatric and adult cases among 38 respondents (47.5%), with 31 (81.4%) extending conservative management and delaying surgical interventions in pediatric cases. Anesthesia preferences for pediatric cases varied, with 40 respondents (50.0%) favoring local anesthesia, 19 (23.8%) opting for monitored anesthesia care, and 13 (16.2%) choosing general anesthesia.
Conclusions This survey of the management of hordeolum and chalazion by KSOPRS members has revealed several interesting common practices that are considered valuable by current practitioners. |
Key Words:
Chalazion, Hordeolum, Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS), Patient care management, Surveys and questionnaires |
|